• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about TAK

    Recent news which mentions TAK

    < Previous 1 2 3 4 5 6 7 Next >
    Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency
    Tickers ASIA NEWS TAK
    Tags Equities News TAK
    From Benzinga
    Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
    Tickers MRK NEWS RHHBY SNY
    Tags Analyst Color TEVA Market News
    From Benzinga
    Keros Therapeutics' Licensing Deal With Takeda Aligns With Broader Opportunity For Elritercept: Analyst
    Tickers KROS NEWS TAK
    Tags Stories That Matter Benzinga Biotech
    From Benzinga
    AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
    Tickers ACIU NEWS TAK
    Tags News pharmaceuticals Health Care
    From Benzinga
    Urgency, Debate Mark COP29 As Leaders Push For Carbon Market Rules, Worry About Trump
    Tickers F FAN ICLN NEWS
    Tags TAN Politics clean energy
    From Benzinga
    Preview: Takeda Pharmaceutical's Earnings
    Tickers TAK
    Tags Market News TAK Earnings
    From Benzinga
    Alumis' Investigational Lead Candidate Supports Superior Profile Than Bristol Myers' Commercialized Drug, Analyst Sees 170% Stock Upside
    Tickers ALMS BMY NEWS TAK
    Tags Analyst Color ALMS Market News
    From Benzinga
    Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
    Tickers JNJ NEWS TAK
    Tags Market News Large Cap News
    From Benzinga
    Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
    Tickers JNJ NEWS PTGX TAK
    Tags Biotech Stories That Matter Benzinga
    From Benzinga
    Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
    Tickers AZN BMY ELVN NEWS
    Tags General Biotech Movers
    From Benzinga
    Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
    Tickers HKMPF HKMPY MCKPF MNKTQ
    Tags Biotech Stories That Matter Benzinga
    From Benzinga
    Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
    Tickers ASND NEWS TAK
    Tags Stories That Matter Benzinga Movers
    From Benzinga
    Why Is Japanese Drugmaker Takeda Pharmaceutical Stock Trading Higher On Wednesday?
    Tickers NEWS TAK
    Tags Benzinga Stories That Matter Biotech
    From Benzinga
    TAK Stock Earnings: Takeda Pharmaceutical Reported Results for Q1 2024
    Tickers TAK
    Tags Earnings Reports TAK Market News
    From InvestorPlace
    3 Biotech Stocks to Buy on the Dip: July 2024
    Tickers JAZZ PCRX TAK
    Tags TAK NASDAQ:JAZZ,NYSE:TAK,NASDAQ:PCRX PCRX
    From InvestorPlace
    Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
    Tickers ALMS BMY JNJ NEWS
    Tags General Stories That Matter Benzinga
    From Benzinga
    Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
    Tickers LLY MORF NEWS TAK
    Tags Analyst Color M&A Market News
    From Benzinga
    Blackstone Nears $2.2B Deal For Sale Of Japanese Supplement Maker Alinamin: Report
    Tickers BX LBO NEWS PSP
    Tags Stories That Matter Benzinga PSP
    From Benzinga
    NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Tickers BTDR LEN NEE NEWS
    Tags Movers NTES Benzinga
    From Benzinga
    Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Tickers AAN AGRI ALLG AMCX
    Tags ZKH CETX BMEA
    From Benzinga
    What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?
    Tickers NEWS OVID TAK
    Tags News Equities Trading Ideas
    From Benzinga
    Japan Pharma Giant Takeda's Anti-Seizure Treatment Flunks In Two Late-Stage Studies
    Tickers NEWS TAK
    Tags Briefs Movers Biotech
    From Benzinga
    7 F-Rated Stocks to Avoid at All Costs in June
    Tickers AKTS BSFC HLTH LCID
    Tags Stocks to Sell TSLA VSTM
    From InvestorPlace
    Blackstone Weighs Sale Of Japanese Pharma Firm Alinamin: Report
    Tickers BX EQBBF NEWS TAK
    Tags News EQBBF Equities
    From Benzinga
    Google DeepMind CEO: ‘This Is the Next $100 Billion AI Business’
    Tickers AZN CRBP JANX MSFT
    Tags AZN Market Analysis CRBP
    From InvestorPlace
    Takeda's Dengue Vaccine Gets WHO Approval, Eligible for UN Procurement
    Tickers NEWS SNY TAK
    Tags Large Cap News SNY
    From Benzinga
    Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
    Tickers ACIU NEWS TAK
    Tags General ACIU Stories That Matter
    From Benzinga
    Why Is AC Immune (ACIU) Stock Up 45% Today?
    Tickers ACIU TAK TVGN
    Tags NASDAQ:ACIU,NYSE:TAK,NASDAQ:TVGN Market News TAK
    From InvestorPlace
    Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
    Tickers NEWS TAK
    Tags why it's moving Market News News
    From Benzinga
    TAK Stock Earnings: Takeda Pharmaceutical Reported Results for Q4 2023
    Tickers TAK
    Tags TAK Market News Earnings Reports
    From InvestorPlace
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.